Retransplant- and Bronchiolitis Obliterans Syndrome-Free Survival among COVID Lung Transplant Recipients: A National Cohort Study.

RATIONALE: There are limited longer-term follow-up data on bronchiolitis obliterans (BOS)- and retransplant-free survival among patients who underwent lung transplantation for coronavirus disease (COVID)-related lung disease. OBJECTIVES: To evaluate…

Preview only. Read the full abstract at the source